• Explore /
  • Poster
  • / Exploratory analysis of percentage of genomic loss of heterozygosity (LOH) in patients with platinum-sensitive recurrent ovarian carcinoma (rOC) in ARIEL3.

Exploratory analysis of percentage of genomic loss of heterozygosity (LOH) in patients with platinum-sensitive recurrent ovarian carcinoma (rOC) in ARIEL3.

Abstract Poster

Authors

Ana Oaknin

Ana Oaknin

Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Ana Oaknin , Jonathan A. Ledermann , Amit M. Oza , Domenica Lorusso , Carol Aghajanian , Andrew Peter Dean , Nicoletta Colombo , Johanne I Weberpals , Andrew R. Clamp , Giovanni Scambia , Alexandra Leary , Robert W. Holloway , David M. O'Malley , Iain A. McNeish , Elizabeth M. Swisher , Teresa Cameron , Sandra Goble , James Sun , Kevin K. Lin , Robert L. Coleman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01968213

Citation

J Clin Oncol 36, 2018 (suppl; abstr 5545)

DOI

10.1200/JCO.2018.36.15_suppl.5545

Abstract #

5545

Poster Bd #

272

Abstract Disclosures

Similar Posters

First Author: Robert L. Coleman

First Author: Robert L. Coleman

First Author: Carol Aghajanian

Poster

2020 ASCO Virtual Scientific Program

Characterization of patients (pts) with long-term responses to rucaparib in recurrent ovarian cancer (OC).

Characterization of patients (pts) with long-term responses to rucaparib in recurrent ovarian cancer (OC).

First Author: Elizabeth M. Swisher